Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity
| Autor: | Maurizio Cattaneo, Mark-Henry Kamga, Seongkyu Yoon |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Cell Count CHO Cells Biochemistry Column (database) Continuous production 03 medical and health sciences Column chromatography Bioreactors Cricetulus Animals Upstream (networking) Biomanufacturing Process engineering Staphylococcal Protein A Productivity Cell Size Chromatography business.industry Antibodies Monoclonal General Medicine Perfusion Resins Synthetic 030104 developmental biology Volume (thermodynamics) Environmental science business Biotechnology |
| Zdroj: | Preparative biochemistrybiotechnology. 48(5) |
| ISSN: | 1532-2297 |
| Popis: | A new integrated continuous biomanufacturing platform for continuous production of antibodies at fixed cell volumes and cell concentrations for extended periods with immediate capture is presented. Upstream antibody production has reached technological maturity, however, the bottleneck for continuous biomanufacturing remains the efficient and cost-effective capture of therapeutic antibodies in an initial chromatography step. In this study, the first successful attempt at using one-column continuous chromatography (OCC) for the continuous capture of therapeutic antibodies produced through alternating tangential flow perfusion is presented. By performing upstream media optimizations, the upstream perfusion rate was reduced to one vessel volume per day (vv/d), increasing antibody titer and reducing the volume of perfusate. In addition, process improvements were performed to increase productivity by 80% over previously reported values. In addition, a real-time method for evaluating column performance to make column switching decisions was developed. This improved productivity coupled with the use of a single-column improved process monitoring and control in OCC compared to multi-column systems. This approach is the first report on using a single column for the implementation of an integrated continuous biomanufacturing platform and offers a cost-effective and flexible platform process for the manufacture of therapeutic proteins. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|